Brainstorm Cell Therapeutics Inc. (BCLI)
Operating Income Growth
-40.42%
Quarterly · Period ending:
BCLI Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-40.42%period ending
Latest reported-40.42%period ending
BCLI Quarterly Operating Income YoY % (-6.19% → -40.42%)
Year-over-year change
High-resolution chart · PNG
BCLI operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -40.4197% | |
| 33.765% | |
| 29.6331% | |
| 32.8412% | |
| 13.7156% | |
| -24.8585% | |
| 33.6178% | |
| 49.4946% | |
| 45.2744% | |
| 51.9705% | |
| 2.2584% | |
| 11.7819% | |
| 28.2176% | |
| 5.9178% | |
| 20.8789% | |
| -29.6381% | |
| -24.0157% | |
| 20.9843% | |
| 45.9403% | |
| -17.6589% | |
| 17.2838% | |
| 16.5985% | |
| -49.9152% | |
| 19.2037% | |
| -52.3574% | |
| -68.5877% | |
| -40.9785% | |
| -71.7512% | |
| -57.3372% | |
| -113.6107% | |
| -2,384.4538% | |
| -35.1171% | |
| -187.1628% | |
| -30.339% | |
| 136.6154% | |
| -46.0317% | |
| -9.3591% | |
| 2.3179% | |
| 53.4717% | |
| 36.2894% | |
| 58.4003% | |
| 17.8231% | |
| 47.5994% | |
| -5.8025% | |
| -82.6121% | |
| -4.4529% | |
| -93.75% | |
| -125.8364% | |
| 12.862% | |
| -95.2821% | |
| -153.8745% | |
| 8.1911% | |
| -78.2713% | |
| -22.9807% | |
| 61.3685% | |
| -58.3784% | |
| 41.1307% | |
| -66.4773% | |
| -92.4554% | |
| -16.5354% | |
| -130.456% | |
| 13.3005% | |
| -683.871% | |
| -7.0826% | |
| -17.1756% | |
| -12.7778% | |
| 86.2222% | |
| 14.9211% | |
| 31.2336% | |
| 52.381% | |
| -13.828% | |
| 52.162% | |
| 11.7034% | |
| 15.2604% | |
| 44.0231% | |
| -63.7079% | |
| -3.6718% | |
| -114.3611% | |
| -15.7807% | |
| 13.5038% | |
| -13.5965% | |
| -12.7286% | |
| 94.4887% | |
| 34.6548% | |
| -8,324.9253% | |
| -1,556.2251% | |
| -113,626.2228% | |
| -14,166.866% | |
| 26.7537% | |
| -630.0729% | |
| 31.41% | |
| 5.707% | |
| -6.188% |